Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Foundation Grant

University of Alberta

$3,148,850.00

Cardiac Metabolism and Signaling in Heart Failure Pathogenesis and Treatment

EF 2018-19

Résumé
Although advancements in therapies to treat cardiovascular disease have reduced the number of deaths of patients with heart disease, these treatments/interventions have ultimately increased the number of people who eventually go on to develop another clinical condition called heart failure. Simply stated, clinical heart failure is a condition that is defined by poor heart function that prevents the heart from pumping enough blood to the rest of the body for proper organ function. As a result, heart failure patients have a very poor quality of life. Although heart failure is often a "chronic" condition, the chances of dying at one year following diagnosis are between 20-30%, even with our most state-of-the-art treatments. Due to the short life expectancy and poor quality of life of the heart failure patient, the increasing amount of people developing heart failure is a major medical concern. A long-standing concept in heart failure is that the failing heart has defects in specific processes that allow the heart to generate enough energy to function normally. Since scientists already know that the failing heart is starved for energy, a new approach to treating heart failure may reside in improving the ability of the heart to use fuels appropriately and thus restore the amount of energy being produced by the heart. The proposed research will investigate what processes involved in energy production are decreased in the failing heart, and will determine if normalizing these processes can improve the function of the heart. We will use this information to develop novel approaches to treating heart failure. Given the accumulating information regarding the occurrence and poor health outcomes associated with heart failure, there is need to identify additional treatment options for this condition in a large and growing population of Canadians.
Programme
Foundation Grant
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
388681
Name
Dyck Jason R
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Foundation Grant
Projecttitle
Cardiac Metabolism and Signaling in Heart Failure Pathogenesis and Treatment
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$3,148,850
Cihrequipment2
$0
Programname2
Foundation Grant
Keyworddelim
Cardiovascular Disease; Molecular Biology
Abstract
Although advancements in therapies to treat cardiovascular disease have reduced the number of deaths of patients with heart disease, these treatments/interventions have ultimately increased the number of people who eventually go on to develop another clinical condition called heart failure. Simply stated, clinical heart failure is a condition that is defined by poor heart function that prevents the heart from pumping enough blood to the rest of the body for proper organ function. As a result, heart failure patients have a very poor quality of life. Although heart failure is often a "chronic" condition, the chances of dying at one year following diagnosis are between 20-30%, even with our most state-of-the-art treatments. Due to the short life expectancy and poor quality of life of the heart failure patient, the increasing amount of people developing heart failure is a major medical concern. A long-standing concept in heart failure is that the failing heart has defects in specific processes that allow the heart to generate enough energy to function normally. Since scientists already know that the failing heart is starved for energy, a new approach to treating heart failure may reside in improving the ability of the heart to use fuels appropriately and thus restore the amount of energy being produced by the heart. The proposed research will investigate what processes involved in energy production are decreased in the failing heart, and will determine if normalizing these processes can improve the function of the heart. We will use this information to develop novel approaches to treating heart failure. Given the accumulating information regarding the occurrence and poor health outcomes associated with heart failure, there is need to identify additional treatment options for this condition in a large and growing population of Canadians.
Competitiondate
201809
Approvedterm2
7 yrs 0 mth
Pinamesdelim
Dyck, Jason R
Approvedterm
7 ans 0 mois
Cihrcontribution2
~ $3,148,850~ $0~